You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

What is Bexsero?

  • Bexsero is a Meningococcal group B Vaccine.
  • It contains four different components from the surface of the bacteria Neisseria meningitidis group B.
  • Bexsero is given to individuals from 2 months of age and older to help protect against disease caused by the Neisseria meningitidis group B bacteria.
  • These bacteria can cause serious, and sometimes life-threatening, infections such as meningitis (inflammation of the covering of the brain and spinal cord) and sepsis (blood poisoning).

How does it work?

The vaccine works by specifically stimulating the body’s natural defence system of the vaccinated person. This results in protection against the disease in most vaccinated people.

Your healthcare professional can advise you on whether you or your child are recommended to receive the Bexsero vaccine.

How is it given?

  • Bexsero is suitable for use in individuals 2 months of age and older.
  • Bexsero (0.5 ml) will be given to you or your child by a healthcare professional. It will be injected into a muscle, usually the thigh for infants or the upper arm for children, adolescents and adults.
  • It is important to follow instructions from your healthcare professional so that you or your child completes the course of injections.

For further information please see the Bexsero patient information leaflet.

Bexsero is a registered trademark of the GlaxoSmithKline group of companies.